Testing effectiveness (Phase 2)Ended earlyNCT00283634
What this trial is testing
Tarceva for Use in Patients With Relapsed or Refractory Metastatic Non-Small Cell Lung Cancer
Who this might be right for
NSCLC
Millennium Pharmaceuticals, Inc.
Showing 20 of 0 results